Estados financieros detallados de Aligos Therapeutics, Inc. (ALGS): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Márgenes de los últimos 12 meses: margen bruto 99.2%, margen operativo -250.6%, margen neto -241.0%.
Al precio actual de $5.05, ALGS presenta beneficios negativos (P/E no significativo) y un ROE del -160.72%. La capitalización bursátil es de $31M.
Cuenta de Resultados (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Ingresos | 0 | 0 | 0 | $4.4M | $13.9M | $15.5M | $3.9M | $2.2M |
| Coste de Ventas | $1.3M | $2.3M | $3.3M | 0 | 0 | 0 | 0 | $930000 |
| Beneficio Bruto | -$1.3M | -$2.3M | -$3.3M | $4.4M | $13.9M | $15.5M | $3.9M | $1.3M |
| I+D | $10.5M | $44.0M | $79.9M | $104.2M | $85.1M | $73.0M | $70.3M | $69.5M |
| Generales y Administrativos | $3.2M | $10.0M | $14.6M | $28.5M | $26.4M | $30.6M | $22.8M | $20.7M |
| Gastos Operativos | $13.7M | $54.0M | $94.5M | $132.7M | $111.5M | $103.7M | $93.1M | $89.2M |
| Beneficio Operativo | -$13.7M | -$54.0M | -$97.8M | -$128.3M | -$97.6M | -$88.1M | -$89.2M | -$88.0M |
| EBITDA | -$12.4M | -$49.9M | -$105.1M | -$124.4M | -$92.3M | -$83.8M | -$128.3M | -$22.9M |
| Gastos por Intereses | 0 | 0 | $10.5M | 0 | 0 | 0 | 0 | 0 |
| Beneficio Antes de Impuestos | -$13.9M | -$52.2M | -$108.4M | -$128.2M | -$95.9M | -$86.9M | -$130.9M | -$23.9M |
| Impuestos | 0 | $85000 | $161000 | $143000 | $106000 | $795000 | $331000 | $314000 |
| Beneficio Neto | -$13.9M | -$52.3M | -$108.5M | -$128.3M | -$96.0M | -$87.7M | -$131.2M | -$24.2M |
| BPA | $-0.66 | $-2.38 | $-3.18 | $-3.22 | $-2.25 | $-3.52 | $-20.94 | $-2.45 |
| BPA Diluido | $-0.66 | $-2.38 | $-3.18 | $-3.22 | $-2.25 | $-3.52 | $-20.94 | $-2.45 |
| Acciones en Circulación (Diluidas) | $21.2M | $21.9M | $34.2M | $39.9M | $42.7M | $24.9M | $6.3M | $9.9M |
Cuenta de Resultados (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Ingresos | $741000 | $169000 | $2.8M | $27.8M |
| Beneficio Bruto | $741000 | -$88000 | $2.8M | $27.8M |
| Beneficio Operativo | -$28.4M | -$21.8M | -$26.9M | -$1.9M |
| EBITDA | -$30.8M | -$19.6M | -$22.4M | $1.6M |
| Beneficio Neto | -$31.5M | -$19.9M | -$23.0M | -$1.5M |
| BPA | $-3.04 | $-1.91 | $-2.21 | $-0.14 |
| BPA Diluido | $-3.04 | $-1.91 | $-2.21 | $-0.14 |
Balance (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Caja y Equivalentes | $24.0M | $69.6M | $220.4M | $186.8M | $81.3M | $135.7M | $37.0M | $18.3M |
| Inversiones a Corto | $66.8M | $48.1M | $23.1M | $3.9M | $44.5M | 0 | $19.9M | $59.5M |
| Cuentas por Cobrar | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $92.4M | $120.2M | $250.0M | $204.4M | $133.5M | $141.1M | $62.1M | $82.9M |
| Inmovilizado Material | $15.2M | $16.1M | $14.9M | $15.0M | $12.5M | $9.8M | $7.3M | $5.0M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $107.7M | $146.5M | $265.3M | $235.4M | $146.7M | $151.5M | $70.1M | $88.5M |
| Cuentas por Pagar | $3.0M | $3.8M | $3.3M | $3.0M | $4.7M | $2.5M | $2.6M | $4.0M |
| Deuda a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Corrientes | $7.5M | $13.8M | $30.3M | $39.0M | $33.1M | $23.9M | $21.7M | $21.2M |
| Deuda a Largo | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Totales | $121.5M | $211.4M | $45.3M | $50.6M | $42.8M | $59.4M | $99.1M | $35.0M |
| Reservas | -$13.9M | -$66.2M | -$174.7M | -$303.1M | -$399.1M | -$486.8M | -$618.0M | -$642.2M |
| Patrimonio Neto | -$13.7M | -$64.9M | $220.0M | $184.7M | $103.9M | $92.1M | -$29.0M | $53.5M |
| Deuda Total | $13.9M | $14.3M | $13.0M | $14.5M | $12.6M | $11.1M | $8.4M | $5.2M |
| Deuda Neta | -$77.0M | -$103.3M | -$230.5M | -$176.3M | -$113.3M | -$124.6M | -$48.6M | -$72.6M |
| Capital Circulante | $84.9M | $106.4M | $219.7M | $165.5M | $100.4M | $117.2M | $40.4M | $61.6M |
Balance (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Caja y Equivalentes | $41.9M | $18.4M | $30.2M | $30.4M |
| Activos Totales | $109.8M | $89.6M | $64.6M | $66.3M |
| Pasivos Totales | $37.9M | $36.0M | $32.8M | $34.4M |
| Patrimonio Neto | $71.8M | $53.5M | $31.8M | $31.9M |
| Deuda Total | $6.1M | $5.2M | $4.4M | $3.5M |
Flujo de Caja (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Beneficio Neto | -$13.9M | -$52.3M | -$108.5M | -$128.3M | -$96.0M | -$87.7M | -$131.2M | -$24.2M |
| Amortizaciones | $1.3M | $2.3M | $3.3M | $3.8M | $3.7M | $3.1M | $2.6M | $2.8M |
| Compensación en Acciones | $179000 | $752000 | $3.0M | $13.5M | $14.7M | $12.7M | $8.5M | $5.0M |
| Cambio en Capital Circulante | $4.9M | $3.7M | $16.1M | -$4.7M | -$1.6M | -$9.5M | -$5.0M | -$3.8M |
| Flujo de Caja Operativo | -$6.0M | -$46.8M | -$74.3M | -$115.7M | -$79.4M | -$79.0M | -$80.7M | -$82.5M |
| Inversiones (CapEx) | -$2.5M | -$2.8M | -$2.1M | -$892000 | -$943000 | -$19000 | -$130000 | -$437000 |
| Adquisiciones | 0 | 0 | 0 | -$3.9M | 0 | 0 | 0 | 0 |
| Recompra de Acciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$8.6M | -$49.6M | -$76.3M | -$116.6M | -$80.3M | -$79.0M | -$80.9M | -$82.9M |
Flujo de Caja (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Flujo de Caja Operativo | -$24.3M | -$21.7M | -$23.1M | -$24.9M |
| Inversiones (CapEx) | -$193000 | -$92000 | -$69000 | -$1000 |
| Flujo de Caja Libre | -$24.5M | -$21.8M | -$23.2M | -$25.0M |
| Dividendos Pagados | 0 | 0 | 0 | 0 |
| Compensación en Acciones | $1.5M | $1.5M | $1.3M | $1.4M |
Crecimiento y Márgenes (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Crecimiento Ingresos (anual) | | | | | +219.0% | +11.7% | -74.6% | -44.6% |
| Crecimiento Beneficio Neto (anual) | | -275.1% | -107.7% | -18.2% | +25.2% | +8.7% | -49.6% | +81.6% |
| Crecimiento BPA (anual) | | -260.6% | -33.6% | -1.3% | +30.1% | -56.4% | -494.9% | +88.3% |
| Cambio en Acciones (anual) | | +3.6% | +55.8% | +16.6% | +7.1% | -41.7% | -74.8% | +57.8% |
| Crecimiento FCF (anual) | | -478.6% | -54.0% | -52.7% | +31.1% | +1.6% | -2.4% | -2.6% |
| Margen Bruto | | | | 100.0% | 100.0% | 100.0% | 100.0% | 57.5% |
| Margen Operativo | | | | -2943.8% | -701.7% | -567.5% | -2259.9% | -4024.9% |
| Margen EBITDA | | | | -2854.1% | -663.4% | -539.7% | -3251.2% | -1049.8% |
| Margen Neto | | | | -2944.1% | -690.6% | -564.6% | -3326.0% | -1106.7% |
| Margen FCF | | | | -2673.9% | -577.6% | -508.8% | -2050.0% | -3794.1% |
| Tasa Impositiva Efectiva | -0.0% | -0.2% | -0.1% | -0.1% | -0.1% | -0.9% | -0.3% | -1.3% |
Datos por Acción (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| FCF por Acción | $-0.40 | $-2.26 | $-2.23 | $-2.92 | $-1.88 | $-3.18 | $-12.91 | $-8.39 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $21.2M | $21.9M | $34.2M | $39.9M | $42.7M | $24.9M | $6.3M | $9.9M |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | -160.72% |
| Rentabilidad sobre capital invertido | -191.73% |
| Rentabilidad sobre activos | -114.53% |
| Margen bruto | 99.18% |
| Margen operativo | -250.63% |
| Margen neto | -241.01% |
Salud financiera
| Deuda / Patrimonio | 0.11 |
| Ratio corriente | 2.19 |
| Piotroski F-Score | 2 |
| Altman Z-Score | -10.99 |
Ratios Clave (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| P/E | -562.50 | -155.99 | -217.37 | -92.16 | -10.59 | -4.72 | -1.90 | -3.80 |
| P/VC | -571.70 | -125.47 | 107.37 | 64.02 | 9.79 | 4.48 | -8.61 | 1.72 |
| P/V | 0.00 | 0.00 | 0.00 | 2713.26 | 73.13 | 26.59 | 63.27 | 42.14 |
| Margen Bruto | 0.0% | 0.0% | 0.0% | 100.0% | 100.0% | 100.0% | 100.0% | 57.5% |
| Margen Operativo | 0.0% | 0.0% | 0.0% | -2943.8% | -701.7% | -567.5% | -2259.9% | -4024.9% |
| Margen Neto | 0.0% | 0.0% | 0.0% | -2944.1% | -690.6% | -564.6% | -3326.0% | -1106.7% |